Premier Biotech (ACP) Acquires OraSure Toxicology Line and Green Earth Biomedical's Mexican Subsidiary (GEM)
April 10, 2025
Premier Biotech, a portfolio company of Align Capital Partners, acquired certain assets comprising OraSure Technologies' substance abuse testing business line and the Mexican subsidiary of Green Earth Biomedical LLC (GEM). The transactions expand Premier's oral-fluid toxicology product portfolio and accelerate its international distribution footprint in Mexico and Latin America.
- Buyers
- Premier Biotech, Align Capital Partners
- Targets
- OraSure Toxicology Line (assets of OraSure Technologies, Inc.), GEM (Mexican subsidiary of Green Earth Biomedical LLC)
- Sellers
- OraSure Technologies, Inc., Green Earth Biomedical LLC
- Platforms
- Premier Biotech
- Industry
- Medical Devices
- Location
- Pennsylvania, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Premier Biotech Acquires Desert Tox
June 6, 2024
Healthcare Services
Premier Biotech, a toxicology testing provider backed by Align Capital Partners, has acquired Desert Tox, LLC, a SAMHSA‑certified laboratory that provides urine and oral fluid testing across HHS/DOT, employment, occupational health and government markets. The founders, Mike Grommes and Mike Gorman, will remain involved; the deal is Premier's first add-on since ACP's acquisition in November 2022 and expands Premier's national service offering and oral fluids capabilities.
-
OraSure Technologies Acquires UrSure
May 29, 2020
Medical Devices
OraSure Technologies, Inc. has agreed to acquire UrSure, Inc., a Boston-based developer of tests that measure adherence to HIV medications including PrEP, for $3 million upfront plus up to $28 million in contingent consideration. The acquisition expands OraSure's point-of-care and infectious disease diagnostic offerings and strengthens its position in the HIV market by adding adherence-monitoring products and related laboratory capabilities.
-
Align Capital Partners Recapitalizes Premier Biotech
December 7, 2022
Medical Devices
Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.
-
Alliance Technical Group Acquires Four Environmental Laboratories Nationwide
November 17, 2023
Environmental Services
Alliance Technical Group, a Morgan Stanley Capital Partners–backed environmental testing and services platform, has acquired four independent environmental laboratories — Summit Environmental Technologies (Cuyahoga Falls, OH), Fremont Analytical (Seattle, WA), Orange Coast Analytical (Los Angeles, CA / Phoenix, AZ) and CHESTER LabNet (Portland, OR) — to build a nationwide laboratory network. The add-on deals expand Alliance's capabilities beyond air testing into water, hazardous waste, soil and PFAS/XRF analyses and broaden its geographic coverage across the United States.
-
Premier Biotech Acquires National Test Systems
November 5, 2025
Medical Devices
Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.
-
ORO Labs Acquires ProcureTech
March 18, 2025
Consulting
ORO Labs, the enterprise-grade procurement orchestration platform, has acquired ProcureTech, a procurement-focused digital accelerator. The acquisition brings ProcureTech’s ~20 procurement experts and partner network into ORO to strengthen EMEA operations, accelerate global growth, and expand orchestration and AI-led procurement capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.